{"organizations": [], "uuid": "5e85b242f2b158e47c05836808f13c016a11e7d6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-palatin-technologies-announces-fda/brief-palatin-technologies-announces-fda-clearance-of-investigational-new-drug-application-for-pl-8177-idUSASB0BZJX", "country": "US", "domain_rank": 408, "title": "BRIEF-Palatin Technologies Announces FDA Clearance Of Investigational New Drug (Ind) Application For Pl-8177", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T14:32:00.000+02:00", "replies_count": 0, "uuid": "5e85b242f2b158e47c05836808f13c016a11e7d6"}, "author": "", "url": "https://www.reuters.com/article/brief-palatin-technologies-announces-fda/brief-palatin-technologies-announces-fda-clearance-of-investigational-new-drug-application-for-pl-8177-idUSASB0BZJX", "ord_in_thread": 0, "title": "BRIEF-Palatin Technologies Announces FDA Clearance Of Investigational New Drug (Ind) Application For Pl-8177", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "fda clearanc", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "palatin technologies inc", "sentiment": "none"}, {"name": "palatin technologies inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 3, 2018 / 12:32 PM / Updated 6 minutes ago BRIEF-Palatin Technologies Announces FDA Clearance Of Investigational New Drug (Ind) Application For Pl-8177 Reuters Staff 1 Min Read \nJan 3 (Reuters) - Palatin Technologies Inc: \n* PALATIN TECHNOLOGIES INC ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR PL-8177 FOR ULCERATIVE COLITIS \n* PALATIN TECHNOLOGIES INC - EXPECTS TO COMMENCE A PHASE 1 SINGLE AND MULTIPLE ASCENDING DOSE STUDY IN CURRENT QUARTER Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-03T14:32:00.000+02:00", "crawled": "2018-01-03T14:47:31.006+02:00", "highlightTitle": ""}